100% FreeCites Clinical GuidelinesNo Registration Needed
GLP-1 & Weight Loss Medication Denial Appeal Generator
Was your Wegovy, Zepbound, or Ozempic claim or prior authorization denied? Generate a customized clinical appeal letter citing FDA indications and insurance review guidelines.
Loading generator…
Key Information & Legal Rights
- FDA criteria: Wegovy, Zepbound, and Saxenda are FDA-approved for adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes).
- Step therapy: Insurers may require failed trials of diet, exercise, and older weight-loss drugs. Document every prior therapy with dates and outcomes.
- Appeal rights: Under ERISA §503 and ACA §2719, you can request internal review, written clinical criteria, and peer-to-peer review with your prescribing physician.
How to Overcome a GLP-1 Insurance Denial
When your GLP-1 medication is denied, the first step is to request the insurer's written denial reason and the specific clinical policy used. Most denials fall into three categories: prior authorization rejection, step therapy requirements, or formulary exclusion.
A strong appeal letter should cite FDA-approved labeling for your medication, document your BMI and comorbidities, list failed prior therapies, and request expedited review under your plan's appeal rights. Including your physician's clinical rationale significantly improves approval rates.
Steps to Submit Your Appeal
- Generate your appeal letter using the tool above with your clinical details.
- Review and edit the letter; add your member ID and claim number.
- Have your prescribing physician review and co-sign if possible.
- Submit via your insurer's appeals portal, fax, or certified mail before the deadline.